R. Aboulker, D. Paris-llado, J. Bucourt, M. Uzan, M. Papiernik et al., Screening with a uterine Doppler in low risk pregnant women followed by low dose aspirin in women with abnormal results: a multicenter randomised controlled trial, BJOG Int J Obstet Gynaecol. mai, vol.108, issue.5, pp.510-518, 2001.

B. Haddad, M. Beaufils, and F. Bavoux, Prise en charge de la pr????clampsie, EMC - Obst??trique, vol.1, issue.3, pp.1-14, 2006.
DOI : 10.1016/S0246-0335(06)43045-3

J. Nizard, Prévention du RCIU vasculaire Journal de Gynécologie Obstétrique et Biologie de la Reproduction, pp.1008-1017, 2013.

F. Park, K. Russo, P. Williams, M. Pelosi, R. Puddephatt et al., Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening, Ultrasound in Obstetrics & Gynecology, vol.30, issue.4, 2015.
DOI : 10.1002/uog.14819

T. Fournier and V. Tsatsaris, Développement du placenta humain et physiopathologie de la pré-éclampsie. Métabolismes Hormones Diabètes et Nutrition (XII), n° 4, juillet-août, 2008.

J. Miller, S. Turan, and A. Baschat, Fetal Growth Restriction, Seminars in Perinatology, vol.32, issue.4, pp.274-80, 2008.
DOI : 10.1053/j.semperi.2008.04.010

URL : https://hal.archives-ouvertes.fr/pasteur-01351893

L. Ghulmiyyah and B. Sibai, Maternal Mortality From Preeclampsia/Eclampsia, Seminars in Perinatology, vol.36, issue.1, pp.56-65, 2012.
DOI : 10.1053/j.semperi.2011.09.011

C. Vaillancourt, J. Lafond, R. Gabriel, and G. Harika, Pregnancy Disorders and Perinatal Outcomes Bentham Science Publishers; 2012. 161 p. 11. RPC_preeclampsie_fr_BM2.pd . Disponible sur: http://www.cngof.asso.fr/D_TELE/RPC_preeclampsie_fr_BM2.pdf 12 Retard de croissance intra-utérin et foetus petits pour l'âge gestationnel, EMC -Obstétrique, vol.10, issue.3, pp.1-17, 2015.

C. Geyl, E. Clouqueur, J. Lambert, D. Subtil, V. Debarge et al., Liens entre prééclampsie et retard de croissance intra-utérin. Gynécologie Obstétrique Fertil, avr, vol.42, issue.4, pp.229-262, 2014.

L. Askie, L. Duley, D. Henderson-smart, and L. Stewart, Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. The Lancet, p.26

S. Roberge, A. Odibo, and E. Bujold, Aspirin for the Prevention of Preeclampsia and Intrauterine Growth Restriction, Clinics in Laboratory Medicine, vol.36, issue.2, pp.319-348, 2016.
DOI : 10.1016/j.cll.2016.01.013

L. Poon, K. Nicolaides, L. Poon, N. Maiz, C. Valencia et al., Early Prediction of Preeclampsia First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia, Obstet Gynecol Int Ultrasound Obstet Gynecol. 1 janv, vol.201433, issue.1, pp.297397-1723, 2009.

M. Leguy, S. Brun, G. Pidoux, H. Salhi, A. Choiset et al., Pattern of secretion of pregnancy-associated plasma protein-A (PAPP-A) during pregnancies complicated by fetal aneuploidy, in vivo and in vitro. 19. Fialova L, Malbohan IM. Pregnancy-associated plasma protein A (PAPP-A): theoretical and clinical aspects, Reprod Biol Endocrinol. Bratisl Lekárske Listy, vol.12103, issue.6, pp.129194-205, 2002.

R. Akolekar, A. Syngelaki, J. Beta, R. Kocylowski, N. Khforgas et al., Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia Low pregnancy-associated plasma protein-a at 10(+1) to 14(+6) weeks of gestation and a possible mechanism leading to miscarriage, Prenat Diagn. déc Fetal Diagn Ther. oct, vol.2919, issue.125, pp.456-61, 2004.

D. Wright, A. Syngelaki, I. Bradbury, R. Akolekar, K. Nicolaides et al., First-Trimester Screening for Trisomies 21, 18 and 13 by Ultrasound and Biochemical Testing, Fetal Diagnosis and Therapy, vol.35, issue.2, pp.118-144, 2014.
DOI : 10.1159/000357430

A. Moety, G. Almohamady, M. Sherif, N. Raslana, A. Mohamed et al., Could first-trimester assessment of placental functions predict preeclampsia and intrauterine growth restriction? A prospective cohort study, J

S. Kløverpris, L. Skov, S. Glerup, K. Pihl, M. Christiansen et al., Formation of high-molecular-weight angiotensinogen during pregnancy is a result of competing redox reactions with the proform of eosinophil major basic protein, Biochemical Journal, vol.282, issue.1, pp.209-226, 2013.
DOI : 10.1159/000112585

K. Pihl, T. Larsen, S. Rasmussen, L. Krebs, and M. Christiansen, The proform of eosinophil major basic protein: a new maternal serum marker for adverse pregnancy outcome, Prenatal Diagnosis, vol.22, issue.1
DOI : 10.1002/pd.2331

J. Beristain, A. Leach, R. Kilburn, B. Wang, J. Liu et al., ADAM12 and PAPP-A: candidate regulators of trophoblast invasion and first trimester markers of healthy trophoblasts. Cell Adhes Migr. 29 sept 2015;0. 28 Heparin-binding EGFlike growth factor regulates human extravillous cytotrophoblast development during conversion to the invasive phenotype, Prenat Diagn. nov Dev Biol. 15 févr, vol.29266, issue.112, pp.223-260, 2004.

M. S. El-sherbiny, W. Nasr, A. Soliman, A. Cowans, N. Stamatopoulou et al., Biochemical markers for prediction of preclampsia: review of the literature Metalloprotease (ADAM12-S) as a predictor of preeclampsia: correlation with severity, maternal complications, fetal outcome, and Doppler parameters ADAM12s in maternal serum as a potential marker of pre-eclampsia, J Prenat Med. Hypertens Pregnancy. Prenat Diagn. mars, vol.53128, issue.3043, pp.69-77, 2008.

Y. Yang, Y. Wang, X. Zeng, X. Ma, Y. Zhao et al., Self-Control of HGF Regulation on Human Trophoblast Cell Invasion via Enhancing c-Met Receptor Shedding by ADAM10 and ADAM17, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.8, 2012.
DOI : 10.1210/jc.2012-1150

S. Zhao, Y. Gu, R. Fan, L. Groome, D. Cooper et al., Proteases and sFlt-1 Release in the Human Placenta, Placenta, vol.31, issue.6, pp.512-520, 2010.
DOI : 10.1016/j.placenta.2010.03.014

T. Hu, G. Wang, Z. Zhu, Y. Huang, H. Gu et al., Increased ADAM10 expression in preeclamptic placentas is associated with decreased expression of hydrogen sulfide production enzymes, Placenta, vol.36, issue.8, pp.947-50, 2015.
DOI : 10.1016/j.placenta.2015.05.007

S. Maynard, J. Min, J. Merchan, K. Lim, J. Li et al., Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia, Journal of Clinical Investigation, vol.111, issue.5, pp.649-58, 2003.
DOI : 10.1172/JCI17189

E. Llurba, F. Chantraine, M. Vatish, A. Staff, and M. Sennström, Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia, PLoS ONE. N Engl J Med, vol.7, issue.11 7, 2012.

R. Cazacu, A. Wright, D. Wright, K. Nicolaides, O. Mendez et al., Serum placental growth factor at 12, 22, 32 and 36 weeks' gestation in screening for preeclampsia Serum soluble fms-like tyrosine kinase-1 at 12, 22, 32 and 36 weeks' gestation in screening for preeclampsia Biophysical and biochemical markers at 30?34 weeks' gestation in the prediction of adverse perinatal outcome, janv Ultrasound Obstet Gynecol. Ultrasound Obstet Gynecol. Ultrasound Obstet Gynecol, vol.374, issue.1, 2015.

S. Benton, Y. Hu, F. Xie, K. Kupfer, S. Lee et al., Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?, ):163.e1-163.e7. 45. Margossian A, Boisson-Gaudin C, Subtil F et al. Impact du retard de croissance intra-utérin sur la concentration sérique maternelle du PlGF, 2012.
DOI : 10.1016/j.ajog.2011.09.019

. Une-Étude-cas-témoin, Gynécologie Obstétrique &amp, pp.23-28, 2016.

I. Herraiz, L. Dröge, E. Gómez-montes, W. Henrich, A. Galindo et al., Characterization of the Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio in Pregnancies Complicated by Fetal Growth Restriction The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction, Obstet Gynecol. août J Perinat Med. janv mars, vol.1244229, issue.2 113, pp.61-69, 2010.

M. Kar, Role of Biomarkers in Early Detection of Preeclampsia, JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, vol.8, issue.4, pp.1-04, 2014.
DOI : 10.7860/JCDR/2014/7969.4261

C. Robinson and D. Johnson, Soluble endoglin as a second-trimester marker for preeclampsia, American Journal of Obstetrics and Gynecology, vol.197, issue.2, pp.174-175, 2007.
DOI : 10.1016/j.ajog.2007.03.058

D. Rios, P. Alpoim, L. Godoi, L. Perucci, L. De-sousa et al., Increased Levels of sENG and sVCAM-1 and Decreased Levels of VEGF in Severe Preeclampsia, American Journal of Hypertension, vol.29, issue.11, 2015.
DOI : 10.1093/ajh/hpv170

D. Darmochwal-kolarz, B. Kolarz, M. Korzeniewski, Z. Kimber-trojnar, J. Patro-malysza et al., Sotiriadis A. Low-dose aspirin plus low-molecular-weight heparin for the prevention of pre-eclampsia: yes, no or maybe A Prevention of Pre-eclampsia with the Use of Acetylsalicylic Acid and Low-molecular Weight Heparin -Molecular Mechanisms Utilisation du sulfate de magnésium en obstétrique. Gynécologie Obstétrique &amp Perinatal complications and long-term neurodevelopmental outcome of infants with intrauterine growth restriction, Aspirin vs Heparin for the Prevention of Preeclampsia, pp.57-53539, 2012.

K. Chalubinski, A. Repa, M. Stammler-safar, and J. Ott, Impact of Doppler sonography on intrauterine management and neonatal outcome in preterm fetuses with intrauterine growth restriction, Ultrasound in Obstetrics & Gynecology, vol.25, issue.3, pp.293-301, 2012.
DOI : 10.1002/uog.9039

L. Devisme, B. Merlot, A. Ego, V. Houfflin-debarge, P. Deruelle et al., A case-control study of placental lesions associated with pre-eclampsia, International Journal of Gynecology & Obstetrics, vol.13, issue.(1), pp.165-173, 2013.
DOI : 10.1016/j.ijgo.2012.08.023

M. Kovo, L. Schreiber, A. Ben-haroush, S. Wand, A. Golan et al., Placental vascular lesion differences in pregnancy-induced hypertension and normotensive fetal growth restriction Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free ?-hCG and with secondtrimester uterine artery Doppler, Am J Obstet Gynecol. juin Prenat Diagn. 1 oct, vol.20225, issue.610, pp.561-562, 2005.

G. Kr, Y. Zhong, C. Ag, L. Odibo, M. Ga et al., The Efficiency of First-Trimester Uterine Artery Doppler, ADAM12, PAPP-A and Maternal Characteristics in the Prediction of Pre-Eclampsia, 1593? 600. 62. Gallot D, Sapin V. Marqueurs biologiques de la prééclampsie, pp.1-7, 2012.

J. Guibourdenche, M. Leguy, and V. Tsatsaris, Biology and markers of preeclampsia

D. Wright, M. Silva, S. Papadopoulos, A. Wright, and K. Nicolaides, Serum pregnancyassociated plasma protein-A in the three trimesters of pregnancy: effects of maternal characteristics and medical history, Ultrasound Obstet Gynecol. 1 juill, vol.46, issue.1, 2015.

E. Lecarpentier, T. Fournier, J. Guibourdenche, and V. Tsatsaris, Physiopathologie de la pr??-??clampsie, La Presse M??dicale, vol.45, issue.7-8, 2016.
DOI : 10.1016/j.lpm.2016.04.016

T. Alahakoon, W. Zhang, B. Trudinger, L. Vw-rebelo, I. Belo et al., Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro-and antiangiogenic profiles Fetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancy al. Early pregnancy maternal and fetal angiogenic factors and fetal and childhood growth: the Generation R Study, J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. déc Growth Factors Chur Switz. déc Hum Reprod, vol.272730, issue.1866, pp.345-51, 2009.

P. Tsao, S. Wei, Y. Su, H. Chou, C. Chen et al., Excess Soluble fms-Like Tyrosine Kinase 1 and Low Platelet Counts in Premature Neonates of Preeclamptic Mothers, PEDIATRICS, vol.116, issue.2, pp.468-72, 2005.
DOI : 10.1542/peds.2004-2240

A. Perales-puchalt, R. Sacedón, N. Perales, and A. , Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction Angiogenic growth factors in maternal and fetal serum in pregnancies complicated with intrauterine growth restriction, Clin Sci. 1 janv J Obstet Gynaecol J Inst Obstet Gynaecol. avr, vol.11234, issue.13, pp.218-238, 2007.

É. Lecarpentier, S. Vieillefosse, B. Haddad, T. Fournier, M. Leguy et al., Placental growth factor (PlGF) and sFlt-1 during pregnancy: physiology, assay and interest in preeclampsia, Ann Biol Clin, vol.74, issue.13, pp.259-67, 2016.

J. Irving and P. Lala, Functional Role of Cell Surface Integrins on Human Trophoblast Cell Migration: Regulation by TGF-??, IGF-II, and IGFBP-1, Experimental Cell Research, vol.217, issue.2, pp.419-446, 1995.
DOI : 10.1006/excr.1995.1105

H. Simpson, S. Robson, J. Bulmer, A. Barber, and F. Lyall, Transforming Growth Factor ?? Expression in Human Placenta and Placental Bed During Early Pregnancy, Placenta, vol.23, issue.1, pp.44-58, 2002.
DOI : 10.1053/plac.2001.0746